High Incidence of HPV-Associated Head and Neck Cancers in FA Deficient Mice Is Associated with E7's Induction of DNA Damage through Its Inactivation of Pocket Proteins

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Park, Jung Wook ^a   Shin, Myeong Kyun ^a   Pitot, Henry C ^a   Lambert, Paul F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; FANCONI ANEMIA GROUP D2 PROTEIN; HISTONE H2AX; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROTEIN P107; PROTEIN P16;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; FANCONI ANEMIA; GENOMIC INSTABILITY; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; ONCOGENE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; CELL PROLIFERATION; DNA DAMAGE; EPITHELIUM; ESOPHAGUS; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HEAD AND NECK NEOPLASMS; HISTONES; INCIDENCE; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS; TONGUE; TUMOR MARKERS, BIOLOGICAL;

EID: 84884506632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075056     Document Type: Article

References (52)

1. Joenje H, Patel KJ, (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2: 446-457. doi:10.1038/35076590. PubMed: 11389461.
2. Moldovan GL, D'Andrea AD, (2009) How the fanconi anemia pathway guards the genome. Annu Rev Genet 43: 223-249. doi:10.1146/annurev-genet-102108-134222. PubMed: 19686080.
3. Crossan GP, Patel KJ, (2012) The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. J Pathol 226: 326-337. doi:10.1002/path.3002. PubMed: 21956823.
4. Kennedy RD, D'Andrea AD, (2005) The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev 19: 2925-2940. doi:10.1101/gad.1370505. PubMed: 16357213.
5. Pichierri P, Rosselli F, (2004) Fanconi anemia proteins and the s phase checkpoint. Cell Cycle 3: 698-700. PubMed: 15136767.
6. Pichierri P, Rosselli F, (2004) The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J 23: 1178-1187. doi:10.1038/sj.emboj.7600113. PubMed: 14988723.
7. Liu T, Ghosal G, Yuan J, Chen J, Huang J, (2010) FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science 329: 693-696. doi:10.1126/science.1192656. PubMed: 20671156.
8. Kim Y, Lach FP, Desetty R, Hanenberg H, Auerbach AD, et al. (2011) Mutations of the SLX4 gene in Fanconi anemia. Nat Genet 43: 142-146. doi:10.1038/ng.750. PubMed: 21240275.
9. Knipscheer P, Räschle M, Smogorzewska A, Enoiu M, Ho TV, et al. (2009) The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science 326: 1698-1701. doi:10.1126/science.1182372. PubMed: 19965384.
10. Long DT, Räschle M, Joukov V, Walter JC, (2011) Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science 333: 84-87. doi:10.1126/science.1204258. PubMed: 21719678.
11. Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, et al. (2003) High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 129: 106-112. doi:10.1001/archotol.129.1.106. PubMed: 12525204.
12. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, et al. (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101: 1249-1256. doi:10.1182/blood-2002-07-2170. PubMed: 12393516.
13. Lowy DR, Gillison ML, (2003) A new link between Fanconi anemia and human papillomavirus-associated malignancies. J Natl Cancer Inst 95: 1648-1650. doi:10.1093/jnci/djg125. PubMed: 14625250.
14. Rosenberg PS, Greene MH, Alter BP, (2003) Cancer incidence in persons with Fanconi anemia. Blood 101: 822-826. doi:10.1182/blood-2002-05-1498. PubMed: 12393424.
15. Rosenberg PS, Socié G, Alter BP, Gluckman E, (2005) Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105: 67-73. doi:10.1182/blood-2004-04-1652. PubMed: 15331448.
16. Gillison ML, (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31: 744-754. doi:10.1053/j.seminoncol.2004.09.011. PubMed: 15599852.
17. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720. doi:10.1093/jnci/92.9.709. PubMed: 10793107.
18. Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, et al. (2003) Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 95: 1718-1721. doi:10.1093/jnci/djg091. PubMed: 14625263.
19. van Zeeburg HJ, Snijders PJ, Wu T, Gluckman E, Soulier J, et al. (2008) Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 100: 1649-1653. doi:10.1093/jnci/djn366. PubMed: 19001603.
20. Hoskins EE, Gunawardena RW, Habash KB, Wise-Draper TM, Jansen M, et al. (2008) Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway. Oncogene 27: 4798-4808. doi:10.1038/onc.2008.121. PubMed: 18438432.
21. Spardy N, Duensing A, Charles D, Haines N, Nakahara T, et al. (2007) The human papillomavirus type 16 E7 oncoprotein activates the Fanconi anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. J Virol 81: 13265-13270. doi:10.1128/JVI.01121-07. PubMed: 17898070.
22. Hoskins EE, Morris TA, Higginbotham JM, Spardy N, Cha E, et al. (2009) Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture. Oncogene 28: 674-685. doi:10.1038/onc.2008.416. PubMed: 19015634.
23. Strati K, Pitot HC, Lambert PF, (2006) Identification of biomarkers that distinguish human papillomavirus(HPV) 2006 Positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A 103: 14152-14157. doi:10.1073/pnas.0606698103. PubMed: 16959885. doi:10.1073/pnas.0606698103 PubMed: 16959885.
24. Strati K, Lambert PF, (2007) Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res 67: 11585-11593.
25. Jabbar S, Shin MK, Pitot HC, Lambert PF, (2010) Strati K. Hum Papillomavirus Type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice. Virology 407: 60-67.
26. Park JW, Pitot HC, Strati K, Park JW, Pitot HC, et al. (2010) Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer. Cancer Res 70: 9959-9968. doi:10.1158/0008-5472.CAN-10-1291. PubMed: 20935219. doi:10.1158/0008-5472.CAN-10-1291 PubMed: 20935219.
27. Song S, Pitot HC, Lambert PF, (1999) The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol 73: 5887-5893. PubMed: 10364340.
28. Herber R, Liem A, Pitot H, Lambert PF, (1996) Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol 70: 1873-1881. PubMed: 8627712.
29. Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, et al. (2003) Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev 17: 2021-2035. doi:10.1101/gad.1103403. PubMed: 12893777.
30. Shin MK, Pitot HC, Lambert PF, (2012) Pocket proteins suppress head and neck cancer. Cancer Res 72: 1280-1289. doi:10.1158/1538-7445.AM2012-1280. PubMed: 22237625.
31. Riley RR, Duensing S, Brake T, Münger K, Lambert PF, et al. (2003) Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 63: 4862-4871. PubMed: 12941807.
32. Tribius S, Ihloff AS, Rieckmann T, Petersen C, Hoffmann M, (2011) Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know. Cancer Lett 304: 71-79. doi:10.1016/j.canlet.2011.02.002. PubMed: 21376458.
33. Birkeland AC, Auerbach AD, Sanborn E, Parashar B, Kuhel WI, et al. (2011) Postoperative clinical radiosensitivity in patients with fanconi anemia and head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 137: 930-934. doi:10.1001/archoto.2011.154. PubMed: 21930984.
34. Gillison ML, Lowy DR, (2004) A causal role for human papillomavirus in head and neck cancer. Lancet 363: 1488-1489. doi:10.1016/S0140-6736(04)16194-1. PubMed: 15135592.
35. Begum S, Cao D, Gillison M, Zahurak M, Westra WH, (2005) Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 11: 5694-5699. doi:10.1158/1078-0432.CCR-05-0587. PubMed: 16115905.
36. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, et al. (2002) S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100: 2414-2420. doi:10.1182/blood-2002-01-0278. PubMed: 12239151.
37. Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, et al. (2002) Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109: 459-472. doi:10.1016/S0092-8674(02)00747-X. PubMed: 12086603.
38. Duensing S, Münger K, (2002) The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62: 7075-7082. PubMed: 12460929.
39. Duensing S, Münger K, (2002) Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene 21: 6241-6248. doi:10.1038/sj.onc.1205709. PubMed: 12214255.
40. Fernandez-Capetillo O, Celeste A, Nussenzweig A, (2003) Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle 2: 426-427. PubMed: 12963833.
41. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A, (2004) H2AX: the histone guardian of the genome. DNA Repair (Amst) 3: 959-967. doi:10.1016/j.dnarep.2004.03.024. PubMed: 15279782.
42. Huh KW, DeMasi J, Ogawa H, Nakatani Y, Howley PM, et al. (2005) Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc Natl Acad Sci U S A 102: 11492-11497. doi:10.1073/pnas.0505337102. PubMed: 16061792.
43. McLaughlin-Drubin ME, Münger K, (2009) The human papillomavirus E7 oncoprotein. Virology 384: 335-344. doi:10.1016/j.virol.2008.10.006. PubMed: 19007963.
44. Münger K, Werness BA, Dyson N, Phelps WC, Harlow E, et al. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8: 4099-4105. PubMed: 2556261.
45. Shin MK, Sage J, Lambert PF, (2012) Inactivating all three rb family pocket proteins is insufficient to initiate cervical cancer. Cancer Res 72: 5418-5427. doi:10.1158/0008-5472.CAN-12-2083. PubMed: 22942253.
46. Sun A, Bagella L, Tutton S, Romano G, Giordano A, (2007) From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem 102: 1400-1404. doi:10.1002/jcb.21609. PubMed: 17979151.
47. Simpson DS, Mason-Richie NA, Gettler CA, Wikenheiser-Brokamp KA, (2009) Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis. Cancer Res 69: 8733-8741. doi:10.1158/0008-5472.CAN-09-1359. PubMed: 19887614.
48. Schaffer BE, Park KS, Yiu G, Conklin JF, Lin C, et al. (2010) Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res 70: 3877-3883. doi:10.1158/0008-5472.CAN-09-4228. PubMed: 20406986.
49. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, et al. (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12: 1599-1609. doi:10.1101/gad.12.11.1599. PubMed: 9620848.
50. Ho VM, Schaffer BE, Karnezis AN, Park KS, Sage J, (2009) The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras. Oncogene 28: 1393-1399. doi:10.1038/onc.2008.491. PubMed: 19151761.
51. Shai A, Pitot HC, Lambert PF, (2010) E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Cancer Res 70: 5064-5073. doi:10.1158/1538-7445.AM10-5064. PubMed: 20530688.
52. Alter BP, Giri N, Savage SA, Quint WG, de Koning MN, et al. (2013) Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: A search for human papillomavirus. Int J Cancer 133: 1513-1515. doi:10.1002/ijc.28157. PubMed: 23558727.